Fernando Schmitt

What is he best known for?

The fields of study he is best known for:

• Cancer
• Gene
• Internal medicine

Pathology, Breast cancer, Cancer, Cancer research and Immunohistochemistry are his primary areas of study. His work in Pathology tackles topics such as Ductal carcinoma which are related to areas like Keratin 5 and Carcinoma in situ. His biological study spans a wide range of topics, including Cadherin and Oncology.

While the research belongs to areas of Cancer, he spends his time largely on the problem of Monocarboxylate transporter 1, intersecting his research to questions surrounding Monocarboxylate transporter. The Cancer research study combines topics in areas such as Epidermal growth factor receptor, Calcitriol receptor, CDH1, Chromogenic in situ hybridization and Growth factor receptor. In his research, Basigin is intimately related to Stomach cancer, which falls under the overarching field of Immunohistochemistry.

His most cited work include:

• BRCA1 dysfunction in sporadic basal-like breast cancer. (514 citations)
• Breast cancer prognostic classification in the molecular era: the role of histological grade (455 citations)
• Basal-like and triple-negative breast cancers: a critical review with an emphasis on the implications for pathologists and oncologists (429 citations)

What are the main themes of his work throughout his whole career to date?

His scientific interests lie mostly in Pathology, Breast cancer, Cancer research, Immunohistochemistry and Cancer. His Pathology study integrates concerns from other disciplines, such as Breast carcinoma and Mammary gland. The study incorporates disciplines such as Tissue microarray, Oncology and Disease in addition to Breast cancer.

His study in Cancer research is interdisciplinary in nature, drawing from both Cancer cell, Cadherin, Immunology and Carcinogenesis. His study of Cytokeratin is a part of Immunohistochemistry. Metastasis and Breast disease are subfields of Cancer in which his conducts study.

He most often published in these fields:

• Pathology (57.65%)
• Breast cancer (40.31%)
• Cancer research (26.70%)

What were the highlights of his more recent work (between 2016-2021)?

• Breast cancer (40.31%)
• Cytopathology (11.22%)
• Radiology (10.54%)

In recent papers he was focusing on the following fields of study:

His primary areas of investigation include Breast cancer, Cytopathology, Radiology, Cytology and Fine-needle aspiration. His Breast cancer research is multidisciplinary, relying on both Cancer research, Oncology and Pathology. His Cancer research research includes elements of Cancer cell, Breast carcinoma, Epidermal growth factor receptor and Viability assay.

Fernando Schmitt has included themes like Ductal carcinoma and In situ hybridization in his Pathology study. Fernando Schmitt has researched Cytopathology in several fields, including Malignancy, Papanicolaou stain, Serous fluid, Medical physics and DNA sequencing. His research in Radiology intersects with topics in Metastatic lesion, Thyroid and Lymph node.

Between 2016 and 2021, his most popular works were:

• An Update on Breast Cancer Multigene Prognostic Tests-Emergent Clinical Biomarkers. (56 citations)
• Consistency and reproducibility of next-generation sequencing and other multigene mutational assays: A worldwide ring trial study on quantitative cytological molecular reference specimens (35 citations)
• Hypoxia promotes breast cancer cell invasion through HIF-1α-mediated up-regulation of the invadopodial actin bundling protein CSRP2 (27 citations)

In his most recent research, the most cited papers focused on:

• Cancer
• Gene
• Internal medicine

Fernando Schmitt spends much of his time researching Cytopathology, Cytology, Radiology, Pathology and Serous fluid. His studies in Cytopathology integrate themes in fields like Liquid-based cytology, Suspicious for Malignancy, CYTOCENTRIFUGE, Computational biology and DNA sequencing. The various areas that Fernando Schmitt examines in his Cytology study include Men who have sex with men, Anoscopy, Anal cytology, Referral and Fine-needle aspiration.

His Pathology research integrates issues from Breast cancer, Stem cell marker and Breast Cancer Prognostic Factor. His Breast cancer research is multidisciplinary, incorporating perspectives in Immunohistochemistry, Primary tumor and Oncology. He interconnects Mesothelioma, Malignancy and Targeted therapy in the investigation of issues within Serous fluid.